190 related articles for article (PubMed ID: 15365683)
1. Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior.
Holmes A; Li Q; Koenig EA; Gold E; Stephenson D; Yang RJ; Dreiling J; Sullivan T; Crawley JN
Psychopharmacology (Berl); 2005 Mar; 178(2-3):276-85. PubMed ID: 15365683
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.
Mayorga AJ; Dalvi A; Page ME; Zimov-Levinson S; Hen R; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1101-7. PubMed ID: 11504807
[TBL] [Abstract][Full Text] [Related]
3. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze.
Holmes A; Kinney JW; Wrenn CC; Li Q; Yang RJ; Ma L; Vishwanath J; Saavedra MC; Innerfield CE; Jacoby AS; Shine J; Iismaa TP; Crawley JN
Neuropsychopharmacology; 2003 Jun; 28(6):1031-44. PubMed ID: 12700679
[TBL] [Abstract][Full Text] [Related]
4. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
[TBL] [Abstract][Full Text] [Related]
5. A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness.
Naudon L; El Yacoubi M; Vaugeois JM; Leroux-Nicollet I; Costentin J
Brain Res; 2002 May; 936(1-2):68-75. PubMed ID: 11988231
[TBL] [Abstract][Full Text] [Related]
6. Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depression.
Flores-Burgess A; Millón C; Gago B; Narváez M; Borroto-Escuela DO; Mengod G; Narváez JA; Fuxe K; Santín L; Díaz-Cabiale Z
Neuropharmacology; 2017 May; 118():233-241. PubMed ID: 28288814
[TBL] [Abstract][Full Text] [Related]
7. [125I]-Galanin binding in brain of wildtype, and galanin- and GalR1-knockout mice: strain and species differences in GalR1 density and distribution.
Jungnickel SR; Gundlach AL
Neuroscience; 2005; 131(2):407-21. PubMed ID: 15708483
[TBL] [Abstract][Full Text] [Related]
8. Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout mice.
Rustay NR; Wrenn CC; Kinney JW; Holmes A; Bailey KR; Sullivan TL; Harris AP; Long KC; Saavedra MC; Starosta G; Innerfield CE; Yang RJ; Dreiling JL; Crawley JN
Neuropeptides; 2005 Jun; 39(3):239-43. PubMed ID: 15944016
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice.
Jones MD; Lucki I
Neuropsychopharmacology; 2005 Jun; 30(6):1039-47. PubMed ID: 15688089
[TBL] [Abstract][Full Text] [Related]
10. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
Rénéric JP; Bouvard M; Stinus L
Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
[TBL] [Abstract][Full Text] [Related]
11. Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABA
Benham RS; Hewage NB; Suckow RF; Engin E; Rudolph U
Behav Brain Res; 2017 Aug; 332():172-179. PubMed ID: 28587819
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests.
Lu X; Ross B; Sanchez-Alavez M; Zorrilla EP; Bartfai T
Neuropeptides; 2008 Aug; 42(4):387-97. PubMed ID: 18554714
[TBL] [Abstract][Full Text] [Related]
13. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
Perona MT; Waters S; Hall FS; Sora I; Lesch KP; Murphy DL; Caron M; Uhl GR
Behav Pharmacol; 2008 Sep; 19(5-6):566-74. PubMed ID: 18690111
[TBL] [Abstract][Full Text] [Related]
14. Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.
Ferrés-Coy A; Santana N; Castañé A; Cortés R; Carmona MC; Toth M; Montefeltro A; Artigas F; Bortolozzi A
Psychopharmacology (Berl); 2013 Jan; 225(1):61-74. PubMed ID: 22820867
[TBL] [Abstract][Full Text] [Related]
15. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems.
Brocardo PS; Budni J; Kaster MP; Santos AR; Rodrigues AL
Neuropharmacology; 2008 Feb; 54(2):464-73. PubMed ID: 18078962
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice.
Holmes A; Yang RJ; Crawley JN
J Mol Neurosci; 2002; 18(1-2):151-65. PubMed ID: 11931346
[TBL] [Abstract][Full Text] [Related]
17. Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level.
Kuteeva E; Wardi T; Lundström L; Sollenberg U; Langel U; Hökfelt T; Ogren SO
Neuropsychopharmacology; 2008 Oct; 33(11):2573-85. PubMed ID: 18172432
[TBL] [Abstract][Full Text] [Related]
18. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Cryan JF; O'Leary OF; Jin SH; Friedland JC; Ouyang M; Hirsch BR; Page ME; Dalvi A; Thomas SA; Lucki I
Proc Natl Acad Sci U S A; 2004 May; 101(21):8186-91. PubMed ID: 15148402
[TBL] [Abstract][Full Text] [Related]
19. A role for galanin N-terminal fragment (1-15) in anxiety- and depression-related behaviors in rats.
Millón C; Flores-Burgess A; Narváez M; Borroto-Escuela DO; Santín L; Parrado C; Narváez JA; Fuxe K; Díaz-Cabiale Z
Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522404
[TBL] [Abstract][Full Text] [Related]
20. Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype.
Angoa-Pérez M; Kane MJ; Briggs DI; Herrera-Mundo N; Sykes CE; Francescutti DM; Kuhn DM
ACS Chem Neurosci; 2014 Oct; 5(10):908-19. PubMed ID: 25089765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
